𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Diaphragm rupture in a liver transplant patient receiving chronic immunosuppressive therapy with sirolimus

✍ Scribed by Gian Luigi Adani; Anna Rossetto; Vittorio Bresadola; Umberto Baccarani

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
44 KB
Volume
16
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A progressive, fatal dystonia-Parkinsoni
A progressive, fatal dystonia-Parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy
✍ Spiridon Papapetropoulos; Jennifer Friedman; Craig Blackstone; Gary I. Kleiner; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 76 KB

## Abstract X‐linked agammaglobulinemia (XLA) is a primary immunodeficiency disorder caused by a mutation in the Bruton agammaglobulinemia tyrosine kinase gene that results in severe B‐cell deficiency. So far, neurological complications of XLA have been primarily related to acute and/or chronic cen

Severe rhabdomyolysis due to rosuvastati
Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy–related dyslipidemia
✍ Ana Moreno; JesΓΊs FortΓΊn; Javier Graus; Miguel A. Rodriguez-GandΓ­a; Carmen Quere πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 70 KB

Statins are relatively safe first-line agents to use in the setting of dyslipidemia associated with immunosuppressive therapy in subjects undergoing liver transplantation, and also in HIV-infected patients with dyslipidemia due to antiretroviral drugs, especially ritonavir-boosted protease inhibitor

A randomized controlled trial of late co
A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function
✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 307 KB πŸ‘ 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin

Loss of serum HBsAg after interferon-A t
Loss of serum HBsAg after interferon-A therapy in liver transplant patients with recurrent hepatitis-B infection
✍ Ben-Ari, Z ;Shmueli, D ;Shapira, Z ;Mor, E ;Tur-Kaspa, R πŸ“‚ Article πŸ“… 1997 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 81 KB πŸ‘ 1 views

Reinfection with hepatitis B virus after orthotopic liver transplantation is nearly universal in patients who have not received posttransplant immunoprophylaxis. Recurrence almost invariably leads to chronic liver disease. Interferon has been used both prophylactically and therapeutically but has no